| |
|
|
|
vTv Therapeutics Inc.  
|
|
2.19 -0.105 (-0.05%) |
07-09 16:00 |
|
Open: |
2.27 |
Pre close: |
2.295 |
Target:
|
3.22
|
|
High: |
2.275 |
Low: |
2.14 |
Resistance:
|
2.76
3.16
|
|
Volume: |
229,013 |
Market Cap: |
150M |
Support:
|
2.11
1.76
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.23
 |
MACD |
MACD(12,26):
|
-0.13 |
|
MA(20): |
2.45 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
2.47 |
Stochastic Oscillator |
%K(14,3):
|
15.07  |
|
MA(250): |
1.97 |
%D(3): |
11.92 |
|
Average Volume(K) |
3-Month: |
43406
|
52-Week |
High:
|
4.23 |
|
10-Days: |
35968 |
Low: |
1.23 |
|
RSI |
RSI(14):
|
36.53 |
Change(%): |
59.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.473 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
45.29 |
|
EPS Est. Current Year |
-1.060 |
Return on Assets (ttm) |
-160.4 |
Shares Float (M) |
9.79 |
|
EPS Est. Next Year |
-2.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
76.63 |
|
EPS Est. Next Quarter |
0.190 |
Qtrly Rev. Growth |
-99.1 |
% Held by Institutions |
1.99 |
|
Forward EPS |
-0.690 |
Gross Profit (p.s.) |
-0.273 |
Shares Short (K) |
1800 |
|
Book Value (p.s.) |
-1.380 |
EBITDA (p.s.) |
-0.512 |
P/E |
-4.63 |
|
Sales Per Share |
0.041 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.59 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-23.13 |
P/S |
53.61 |
|
Operating Margin |
-1256.13 |
Levered Free Cash Flow
(M) |
-15.72 |
P/CF |
-4.29 |
|
|
|
|
|
|
